Dario Amodei, CEO of Anthropic, stated that AI regulation should be used to curb the power of frontier labs by providing a competitive edge to smaller challengers. Responding to criticism from investor Gavin Baker, Amodei cited California’s SB 53, which exempts companies with less than $500 million in revenue or training costs from compliance burdens. He voiced support for a reported Trump administration strategy focusing on pre-deployment testing for frontier models and open-weights systems.

Amodei denied that his warnings about AI risks contributed to public mistrust, calling the trend a "crisis of trust" in the technology industry. He pointed to Anthropic's efforts in biology and medicine as the primary way to rebuild credibility, forecasting that AI could cure most human diseases in 5 to 10 years. This expansion aims to deliver concrete results that Amodei believes will prove more effective than marketing campaigns in restoring trust.

Sign in to suggest edits

Key sources

  1. SOURCE@darioamodei“We try very hard to make proposals that disadvantage (slow down) frontier AI companies while *advantaging* smaller competitors”x.com
  2. SOURCE@darioamodei“showing why I think it will actually be possible to cure most human disease in ~5-10 years”x.com
  3. SUPPORT@gavinsbaker“Essentially every major company other than Anthropic has signed Jensen’s letter”x.com
  4. SUPPORT@alexrkonrad“A very rare tweet thread from Anthropic’s CEO”x.com
  5. SUPPORT@shiringhaffary“I think it is fundamentally a crisis of trust”x.com
Markdown